|
|
Volumn 47, Issue 2, 2002, Pages 219-222
|
|
Update: Treatment of systemic lupus erythematosus
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABETIMUS;
AZATHIOPRINE;
CD19 ANTIGEN;
CD3 ANTIGEN;
CD4 ANTIGEN;
CD40 LIGAND;
CD8 ANTIGEN;
CREATININE;
CYCLOPHOSPHAMIDE;
DNA ANTIBODY;
GLUCOCORTICOID;
HYDROXYCHLOROQUINE;
IMMUNOSUPPRESSIVE AGENT;
INTERLEUKIN 10;
INTERLEUKIN 10 ANTIBODY;
INTERLEUKIN 2;
METHOTREXATE;
METHYLPREDNISOLONE;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY B N10;
MONOCLONAL ANTIBODY HU 5C8;
MONOCLONAL ANTIBODY IDEC 131;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
NONSTEROID ANTIINFLAMMATORY AGENT;
PLACEBO;
PREDNISOLONE;
PREDNISONE;
SODIUM CHLORIDE;
T LYMPHOCYTE RECEPTOR;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
AMENORRHEA;
CHILL;
CLINICAL TRIAL;
DIARRHEA;
DRUG EFFECT;
DRUG EFFICACY;
DRUG HALF LIFE;
HEADACHE;
HUMAN;
IMMUNOLOGICAL TOLERANCE;
IMMUNOSUPPRESSIVE TREATMENT;
LUPUS ERYTHEMATOSUS NEPHRITIS;
NAUSEA;
NONHUMAN;
OSTEOPOROSIS;
OUTCOMES RESEARCH;
PROGNOSIS;
RELAPSE;
REMISSION;
REVIEW;
SYSTEMIC LUPUS ERYTHEMATOSUS;
TREATMENT OUTCOME;
VERTIGO;
|
|
EID: 0036222683
PISSN: 21514658
EISSN: None
Source Type: Journal
DOI: 10.1002/art.10289 Document Type: Review |
|
Times cited : (2)
|
|
References (14)
|
